Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion

Journal of Leukocyte Biology

Volumn 82, Issue 5, 2007, Pages 1212-1220

  Elia, Chiara ^a   Cassol, Edana ^a   Sidenius, Nicolai ^a,b   Blasi, Francesco ^a,b,c   Castagna, Antonella ^a   Poli, Guido ^a,c   Alfano, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Acute infection; AIDS; Amino terminal fragment; Chronic infection; Inflammation

Indexed keywords

INTERLEUKIN 6; PLASMINOGEN ACTIVATOR; UROKINASE; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; SERUM; UPREGULATION; VIRUS EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

CELL ADHESION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYMPHOCYTES; MONOCYTES; PROTEIN BINDING; RECEPTORS, CELL SURFACE; TETRADECANOYLPHORBOL ACETATE; U937 CELLS; URINARY PLASMINOGEN ACTIVATOR; VIRUS REPLICATION; VITRONECTIN;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 36248931041     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0407251     Document Type: Article

References (79)

1. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266.
2. Blasi, F., Vassalli, J. D., Dano, K. (1987) Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol. 104, 801-804.
3. Gyetko, M. R., Libre, E. A., Fuller, J. A., Chen, G. H., Toews, G. (1999) Urokinase is required for T lymphocyte proliferation and activation in vitro. J. Lab. Clin. Med. 133, 274-288.
4. May, A. E., Kanse, S. M., Lund, L. R., Gisler, R. H., Imhof, B. A., Preissner, K. T. (1998) Urokinase receptor (CD87) regulates leukocyte recruitment via β 2 integrins in vivo. J. Exp. Med. 188, 1029-1037.
5. Chavakis, T., Kanse, S. M., May, A. E., Preissner, K. T. (2002) Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochem. Soc. Trans. 30, 168-173.
6. Blasi, F., Carmeliet, P. (2002) uPAR: a versatile signaling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943.
7. Sidenius, N., Sier, C. F., Ullum, H., Pedersen, B. K., Lepri, A. C., Blasi, F., Eugen-Olsen, J. (2000) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96, 4091-4095.
8. Lawn, S. D., Myer, L., Bangani, N., Vogt, M., Wood, R. (2007) Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa. BMC Infect. Dis. 7, 41.
9. Cinque, P., Nebuloni, M., Santovito, M. L., Price, R. W., Gisslen, M., Hagberg, L., Bestetti, A., Vago, G., Lazzarin, A., Blasi, F., Sidenius, N. (2004) The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann. Neurol. 55, 687-694.
10. Wada, M., Wada, N. A., Shirono, H., Taniguchi, K., Tsuchie, H., Koga, J. (2001) Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication. Biochem. Biophys. Res. Commun. 284, 346-351.
11. Alfano, M., Sidenius, N., Panzeri, B., Blasi, F., Poli, G. (2002) Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc. Natl. Acad. Sci. USA 99, 8862-8867.
12. Ossowski, L., Aguirre-Ghiso, J. A. (2000) Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 12, 613-620.
13. Blasi, F. (1997) uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today 18, 415-417.
14. Kjoller, L. (2002) The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility. Biol. Chem. 383, 5-19.
15. Cubellis, M. V., Nolli, M. L., Cassani, G., Blasi, F. (1986) Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J. Biol. Chem. 261, 15819-15822.
16. Goletti, D., Kinter, A. L., Hardy, E. C., Poli, G., Fauci, A. S. (1996) Modulation of endogenous IL-1 β and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J. Immunol. 156, 3501-3508.
17. Poli, G., Kinter, A., Justement, J. S., Kehrl, J. H., Bressler, P., Stanley, S., Fauci, A. S. (1990) Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87, 782-785.
18. Poli, G., Kinter, A. L., Justement, J. S., Bressler, P., Kehrl, J. H., Fauci, A. S. (1991) Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J. Exp. Med. 173, 589-597.
19. Curnis, F., Gasparri, A., Sacchi, A., Longhi, R., Corti, A. (2004) Coupling tumor necrosis factor-α with αV integrin ligands improves its antineoplastic activity. Cancer Res. 64, 565-571.
20. Zheng, X., Saunders, T. L., Camper, S. A., Samuelson, L. C., Ginsburg, D. (1995) Vitronectin is not essential for normal mammalian development and fertility. Proc. Natl. Acad. Sci. USA 92, 12426-12430.
21. Goletti, D., Kinter, A. L., Biswas, P., Bende, S. M., Poli, G., Fauci, A. S. (1995) Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J. Virol. 69, 2540-2546.
22. Pomerantz, R. J., Feinberg, M. B., Trono, D., Baltimore, D. (1990) Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172, 253-261.
23. Koup, R. A., Ho, D. D., Poli, G., Fauci, A. S. (1993) Isolation and quantitation of HIV in peripheral blood. Current Protocols in Immunology, New York, NY, USA, John Wiley & Sons, 12.2.1-12.2.11.
24. Alfano, M., Vallanti, G., Biswas, P., Bovolenta, C., Vicenzi, E., Mantelli, B., Pushkarsky, T., Rappuoli, R., Lazzarin, A., Bukrinsky, M., Poli, G. (2001) The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells. J. Immunol. 166, 1863-1870.
25. Schindler, M., Wurfl, S., Benaroch, P., Greenough, T. C., Daniels, R., Easterbrook, P., Brenner, M., Munch, J., Kirchhoff, F. (2003) Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77, 10548-10556.
26. Folks, T. M., Justement, J., Kinter, A., Schnittman, S., Orenstein, J., Poli, G., Fauci, A. S. (1988) Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140, 1117-1122.
27. Rizzi, C., Crippa, M. P., Jeeninga, R. E., Berkhout, B., Blasi, F., Poli, G., Alfano, M. (2006) Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1. J. Immunol. 176, 999-1006.
28. Cassol, E., Alfano, M., Biswas, P., Poli, G. (2006) Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J. Leukoc. Biol. 80, 1018-1030.
29. Waltz, D. A., Sailor, L. Z., Chapman, H. A. (1993) Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91, 1541-1552.
30. Yee, J. K., Friedmann, T., Burns, J. C. (1994) Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43 Pt A, 99-112.
31. Rao, N. K., Shi, G. P., Chapman, H. A. (1995) Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression. J. Clin. Invest. 96, 465-474.
32. Luikart, S., Masri, M., Wahl, D., Hinkel, T., Beck, J. M., Gyetko, M. R., Gupta, P., Oegema, T. (2002) Urokinase is required for the formation of mactinin, an α-actinin fragment that promotes monocyte/macrophage maturation. Biochim. Biophys. Acta 1591, 99-107.
33. Paysant, J., Vasse, M., Soria, J., Lenormand, B., Pourtau, J., Vannier, J. P., Soria, C. (1998) Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen. Br. J. Haematol. 100, 45-51.
34. Shen, M., Horbett, T. A. (2001) The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J. Biomed. Mater. Res. 57, 336-345.
35. Shattock, R. J., Friedland, J. S., Griffin, G. E. (1993) Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation. J. Virol. 67, 3569-3575.
36. Biswas, P., Poli, G., Kinter, A. L., Justement, J. S., Stanley, S. K., Maury, W. J., Bressler, P., Orenstein, J. M., Fauci, A. S. (1992) Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176, 739-750.
37. Kinter, A. L., Biswas, P., Alfano, M., Justement, J. S., Mantelli, B., Rizzi, C., Gatti, A. R., Vicenzi, E., Bressler, P., Poli, G. (2001) Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected u1 cells by a long terminal repeat independent post-transcriptional mechanism. Mol. Med. 7, 668-678.
38. Ruoslahti, E., Pierschbacher, M. D. (1987) New perspectives in cell adhesion: RGD and integrins. Science 238, 491-497.
39. Reddy, K. V., Mangale, S. S. (2003) Integrin receptors: the dynamic modulators of endometrial function. Tissue Cell 35, 260-273.
40. Sidenius, N., Andolfo, A., Fesce, R., Blasi, F. (2002) Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J. Biol. Chem. 277, 27982-27990.
41. Deng, G., Curriden, S. A., Hu, G., Czekay, R. P., Loskutoff, D. J. (2001) Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. J. Cell. Physiol. 189, 23-33.
42. Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., Chapman, H. A. (1996) Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.
43. Wei, Y., Yang, X., Liu, Q., Wilkins, J. A., Chapman, H. A. (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144, 1285-1294.
44. Wei, Y., Eble, J. A., Wang, Z., Kreidberg, J. A., Chapman, H. A. (2001) Urokinase receptors promote β1 integrin function through interactions with integrin α3β1. Mol. Biol. Cell 12, 2975-2986.
45. Wei, Y., Czekay, R. P., Robillard, L., Kugler, M. C., Zhang, F., Kim, K. K., Xiong, J. P., Humphries, M. J., Chapman, H. A. (2005) Regulation of α5β1 integrin conformation and function by urokinase receptor binding. J. Cell Biol. 168, 501-511.
46. Degryse, B., Resnati, M., Rabbani, S. A., Villa, A., Fazioli, F., Blasi, F. (1999) Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 94, 649-662.
47. Degryse, B., Resnati, M., Czekay, R. P., Loskutoff, D. J., Blasi, F. (2005) Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J. Biol. Chem. 280, 24792-24803.
48. Aguirre Ghiso, J. A., Kovalski, K., Ossowski, L. (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147, 89-104.
49. Simon, D. I., Wei, Y., Zhang, L., Rao, N. K., Xu, H., Chen, Z., Liu, Q., Rosenberg, S., Chapman, H. A. (2000) Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275, 10228-10234.
50. Madsen, C. D., Sarra Ferraris, G. M., Andolfo, A. P., Cunningham, O., Sidenius, N. (2007) uPAR-induced cell adhesion and migration: vitronectin provides the key. J. Cell Biol. 177, 927-939.
51. Kjoller, L., Hall, A. (2001) Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152, 1145-1157.
52. Porcheray, F., Samah, B., Leone, C., Dereuddre-Bosquet, N., Gras, G. (2006) Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 349, 112-120.
53. Lin, T. H., Yurochko, A., Kornberg, L., Morris, J., Walker, J. J., Haskill, S., Juliano, R. L. (1994) The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes. J. Cell Biol. 126, 1585-1593.
54. Rosengart, M. R., Arbabi, S., Bauer, G. J., Garcia, I., Jelacic, S., Maier, R. V. (2002) The actin cytoskeleton: an essential component for enhanced TNFα production by adherent monocytes. Shock 17, 109-113.
55. Cuschieri, J., Gourlay, D., Bulger, E., Garcia, I., Jelacic, S., Maier, R. V. (2002) Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. Surgery 132, 157-166.
56. Alfano, M., Poli, G. (2005) Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol. Immunol. 42, 161-182.
57. Krause, S. W., Kreutz, M., Andreesen, R. (1996) Differential effects of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. Immunobiology 196, 522-534.
58. Adib-Conquy, M., Petit, A. F., Marie, C., Fitting, C., Cavaillon, J. M. (1999) Paradoxical priming effects of IL-10 on cytokine production. Int. Immunol. 11, 689-698.
59. Naif, H. M., Li, S., Ho-Shon, M., Mathijs, J. M., Williamson, P., Cunningham, A. L. (1997) The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J. Immunol. 158, 501-511.
60. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
61. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
62. van Hinsbergh, V. W., Koolwijk, P., Hanemaaijer, R. (1997) Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. EXS 79, 391-411.
63. Gyetko, M. R., Aizenberg, D., Mayo-Bond, L. (2004) Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J. Leukoc. Biol. 76, 648-656.
64. Newman, S. L., Tucci, M. A. (1990) Regulation of human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J. Clin. Invest. 86, 703-714.
65. Gu, J. M., Johns, A., Morser, J., Dole, W. P., Greaves, D. R., Deng, G. G. (2005) Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice. J. Cell. Physiol. 204, 73-82.
66. Eierman, D. F., Johnson, C. E., Haskill, J. S. (1989) Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142, 1970-1976.
67. Cunningham, O., Andolfo, A., Santovito, M. L., Iuzzolino, L., Blasi, F., Sidenius, N. (2003) Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22, 5994-6003.
68. Gomez, C., Hope, T. J. (2005) The ins and outs of HIV replication. Cell. Microbiol. 7, 621-626.
69. Simons, K., Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39.
70. Sitrin, R. G., Pan, P. M., Harper, H. A., Todd III, R. F., Harsh, D. M., Blackwood, R. A. (2000) Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils. J. Immunol. 165, 3341-3349.
71. Van den Berg, C. W., Cinek, T., Hallett, M. B., Horejsi, V., Morgan, B. P. (1995) Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca(2+)-signaling competent. J. Cell Biol. 131, 669-677.
72. Hiscox, S., Hallett, M. B., Morgan, B. P., van den Berg, C. W. (2002) GPI-anchored GFP signals Ca2+ but is homogeneously distributed on the cell surface. Biochem. Biophys. Res. Commun. 293, 714-721.
73. Choudhury, S., el-Farrash, M. A., Kuroda, M. J., Harada, S. (1996) Retention of HIV-1 inside infected MOLT-4 cells in association with adhesion-induced cytoskeleton reorganization. AIDS 10, 363-368.
74. Sidenius, N., Nebuloni, M., Sala, S., Zerbi, P., Price, R. W., Gisslen, M., Hagberg, L., Vago, L., Lazzarin, A., Blasi, F., Cinque, P. (2004) Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J. Neuroimmunol. 157, 133-139.
75. Ostrowski, S. R., Katzenstein, T. L., Pedersen, M., Hoyer-Hansen, G., Gerstoft, J., Pedersen, B. K., Ullum, H. (2006) Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy. Scand. J. Immunol. 63, 478-486.
76. Sporer, B., Koedel, U., Popp, B., Paul, R., Pfister, H. W. (2005) Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients. J. Neuroimmunol. 163, 190-194.
77. Kruszka, P. (2000) Intra-arterial prourokinase effective for acute stroke therapy. J. Fam. Pract. 49, 267-268.
78. Cross III, D. T., Derdeyn, C. P., Moran, C. J. (2001) Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator. AJNR Am. J. Neuroradiol. 22, 521-525.
79. Cubellis, M. V., Wun, T. C., Blasi, F. (1990) Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 9, 1079-1085.